scholarly journals 365Disease burden of mumps in Japan: descriptive epidemiology based on the health insurance reimbursement database

2021 ◽  
Vol 50 (Supplement_1) ◽  
Author(s):  
Satoko Ohfuji ◽  
Akira Takagi ◽  
Takashi Nakano ◽  
Hideaki Kumihashi ◽  
Munehide Kano ◽  
...  
Keyword(s):  
Health Insurance ◽  
Vaccination Coverage ◽  
Disease Burden ◽  
Descriptive Epidemiology ◽  
Immunization Program ◽  
Health Insurance Reimbursement ◽  
Insurance Reimbursement ◽  
National Immunization ◽  
Icd 10 ◽  
Reimbursement Database

Abstract Background In Japan, mumps vaccination coverage is low, since it is a voluntary vaccination. In this situation, the number of mumps cases as reported by pediatric sentinel hospitals suggests the occurrence of periodical mumps outbreaks. Methods To examine the annual incidences of mumps and mumps-related complications, we analyzed data from the health insurance reimbursement database for subscribers aged 0-64 years between 2005 and 2017. Cases with mumps and mumps-related complications including meningitis, orchitis, deafness, were extracted according to ICD-10 codes entered into the disease section for health insurance reimbursement. Results During the 13 year period, 68,307 of 5,209,660 subjects were reimbursed for mumps, with an incidence of 325 per 100,000 person-years (95% confidence interval (CI): 323-328). Among the 68,307 mumps cases, 787 were reimbursed for mumps-related complications, with an incidence of 11.5 per 1,000 mumps cases (95% CI: 10.7-12.4). Incidence of mumps-related complications (per 1,000 mumps cases) was highest for orchitis (6.6), followed by meningitis (5.8), deafness (1.3), pancreatitis (0.5), and encephalitis (0.3). Mumps incidence was highest among children aged 0-5 years, while incidence of mumps-related complications was highest among adults aged 26-35 years. Conclusions In Japan, the disease burden of mumps remains high among adults, as well as children. Key messages To reduce the disease burden of mumps among all ages in Japan, immunization in childhood is required. A national immunization program for children would result in high vaccination coverage and lower disease burden.

scholarly journals Mumps-related Disease Burden in Japan: Analysis of JMDC Health Insurance Reimbursement Data for 2005–2017

2020 ◽  
Author(s):  
Satoko Ohfuji ◽  
Akira Takagi ◽  
Takashi Nakano ◽  
Hideaki Kumihashi ◽  
Munehide Kano ◽  
...  
Keyword(s):  
Health Insurance ◽  
Disease Burden ◽  
Related Disease ◽  
Health Insurance Reimbursement ◽  
Insurance Reimbursement

scholarly journals Incomplete vaccination for conjugated meningococcal C and hepatitis B at municipal, state and federal level: 2015 a 2019

2021 ◽  
Vol 14 (11) ◽  
Author(s):  
Mariana Dias de Borba ◽  
Carlos Eduardo da Cunha Nascimento ◽  
Gabriel Mael Sussuarana Silva Lobo ◽  
Lucca Gonçalo de Castro Lima ◽  
Camila Lays Winter ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Vaccination Coverage ◽  
Vaccine Coverage ◽  
Cross Sectional Study ◽  
The State ◽  
National Immunization Program ◽  
Immunization Program ◽  
Cross Sectional ◽  
Mato Grosso ◽  
National Immunization

Brazil has the National Immunization Program for disease prevention that offers nineteen vaccines, yet it is known that vaccination coverage according to age is not always reached. Thus, this study aimed to evaluate the vaccination coverage in the municipality of Sinop, in the Mato Grosso state and in the Brazil for meningococcal C conjugate vaccines and Hepatitis B in the period from 2015 to 2019. Method: This is a descriptive, retrospective and cross-sectional study, with data available in the Information System of the National Immunization Program. Results: Vaccination coverage for mingococcal C in children under one year in Sinop was above the target in 2015 and 2018, Mato Grosso was above only in 2015, for the booster dose only Sinop was above the target in 2016. Coverage for hepatitis B in children under 30 days of life demonstrated that Sinop had coverage above the state of Mato Grosso, which in turn was above Brazil. For children under 1 year old, only in 2016 and 2019 the state presented greater vaccination coverage at the expense of Sinop and Brazil. Conclusion: The results demonstrate that there is hesitation on the part of the population regarding vaccination, being greater in vaccines such as meningococcal C. Strengthening childcare is the key to improving the panorama of vaccine coverage.

scholarly journals What is the importance of vaccine hesitancy in the drop of vaccination coverage in Brazil?

2018 ◽  
Vol 52 ◽  
pp. 96 ◽  
Author(s):  
Ana Paula Sayuri Sato
Keyword(s):  
Health Services ◽  
Vaccination Coverage ◽  
North American ◽  
Scientific Research ◽  
Vaccine Hesitancy ◽  
Public Administrators ◽  
National Immunization Program ◽  
Immunization Program ◽  
National Immunization ◽  
Over Time

The successful Programa Nacional de Imunizações do Brasil (Brazilian National Immunization Program) has been experiencing a major challenge with regard to vaccination coverage for children, which has been dropping. Several aspects are related, but certainly vaccine hesitancy has been strengthening itself as one of the main concerns of Brazilian public administrators and researchers. Vaccine hesitancy is the delay in acceptance or refusal despite having the recommended vaccines available in health services, being a phenomenon that varies over time, over location and over types of vaccines. Hesitant individuals are between the two poles of total acceptance and refusal of vaccination. Vaccine hesitancy is nothing new in European and North-American countries, and even in Brazil, it has been studied even if under another name. The drop of vaccination coverage observed from 2016 on reiterates the relevance of the theme, which must be better understood through scientific research.

Sign in / Sign up

Export Citation Format

Share Document